Table of Contents
Analgesics in Australia
Euromonitor International
May 2009
List of
Contents and Tables
Executive Summary
OTC Healthcare Continues To Grow
Steadily
Symbion Health Ltd Undergoes Multiple Acquisitions
Symbion
Health Ltd Retains Lead in OTC Healthcare
Retail Pressure Heat Up As
Grocery Retailers Continue To Strengthen
Moderate Growth Expected Over
Forecast Period
Key Trends and Developments
Convenience Featuring
Highly in Both Product Development and Distribution
Preference for Branded
Products Over Generics and Private Label
Child-specific Products
Experience Growth
Negative Publicity Associated With Side Effects of OTC
Healthcare
Rising Retail Pressures for Chemists/pharmacies
Market
Indicators
Table 1 Consumer Expenditure on Health Goods and Medical
Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market
Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table
4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC
Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand
Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector
2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: %
Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and
Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC
Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC
Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
Vitamins and Dietary Supplements
Registration and Classification
Self-medication and Preventative
Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches
2005-2008
Definitions
Summary 2 Research Sources
Ego
Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 3
Ego Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Ego Pharmaceuticals Pty
Ltd: Competitive Position 2008
Herron Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 5 Herron Pharmaceuticals Pty
Ltd: Key Facts
Company Background
Production
Competitive
Positioning
Summary 6 Herron Pharmaceuticals Pty Ltd: Competitive Position
2008
Inova Pharmaceuticals (australia) Pty Ltd
Strategic Direction
Key Facts
Summary 7 iNova Pharmaceuticals (Australia) Pty Ltd: Key
Facts
Company Background
Production
Summary 8 iNova
Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2008
Competitive Positioning
Summary 9 iNova Pharmaceuticals (Australia) Pty
Ltd: Competitive Position 2008
Pharmacare Laboratories Pty Ltd
Strategic Direction
Key Facts
Summary 10 Pharmacare Laboratories Pty
Ltd: Key Facts
Company Background
Production
Competitive
Positioning
Summary 11 Pharmacare Laboratories Pty Ltd: Competitive
Position 2008
Symbion Health Ltd
Strategic Direction
Key Facts
Summary 12 Symbion Health Ltd: Key Facts
Summary 13 Symbion Health Ltd:
Operational Indicators
Company Background
Production
Summary 14
Symbion Health Ltd: Production Statistics 2008
Competitive Positioning
Summary 15 Symbion Health Ltd: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector
Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table
13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14
Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical
Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics
Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by
Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value
2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value
Growth 2008-2013
| 
View Cart
